Moderna @moderna_tx · 27 Aug 2026
Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of https://t.co/Ydu7Dmef3P
92 367Views
379Likes
98Reposts
0Replies
77Quotes
69Bookmarks
Is that a lot?
1.00×vs this author's median92 367 views is typical
40Percentile for this authorof 5 recent posts
10.3×vs 100K–1M median8 935 views is typical
63.50%Reachviews ÷ followers
0.60%Engagement rateof viewers reacted